After PCI and 1 mo of DAPT for ACS, ticagrelor alone vs. continued DAPT for 11 mo reduced bleeding without increasing MACCE.

Autor: Clifford, Cole, Yan, Andrew T.
Předmět:
Zdroj: Annals of Internal Medicine; Aug2024, Vol. 177 Issue 8, pJC86-JC86, 1p
Abstrakt: Source Citation: Ge Z, Kan J, Gao X, et al; ULTIMATE-DAPT investigators. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial. Lancet. 2024;403:1866-1878. 38599220 Clinical Impact Ratings: GIM/FP/GP: 6 out of 7 Cardiology: 5 out of 7 [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index